Skip to content
healthcare.dev
Get a free key

Quality Choice Cetirizine Hydrochloride

NDC 63868-132, Cetirizine Hydrochloride, tablet, from Chain Drug Marketing Association Inc..

Product NDC
63868-132
Status
Listed
Labeler
Chain Drug Marketing Association Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA077498
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63868-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
63868-132-146386801321414 TABLET in 1 BLISTER PACK (63868-132-14)
63868-132-306386801323030 TABLET in 1 BOTTLE (63868-132-30)
63868-132-906386801329090 TABLET in 1 BOTTLE (63868-132-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63868-132 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63868-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63868-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.